Drug Type ASO |
Synonyms ARRx, ISIS ARRX, ISIS-ARRx + [9] |
Target |
Action inhibitors |
Mechanism AR-v7 inhibitors(androgen receptor splice variant 7 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| AR-V7 positive Castration-Resistant Prostatic Cancer | Phase 2 | China | 24 Mar 2021 | |
| AR-V7 positive Castration-Resistant Prostatic Cancer | Phase 2 | China | 24 Mar 2021 | |
| Metastatic castration-resistant prostate cancer | Phase 2 | China | 24 Mar 2021 | |
| Metastatic castration-resistant prostate cancer | Phase 2 | China | 24 Mar 2021 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 May 2014 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | United Kingdom | 01 May 2014 |
Phase 1 | 9 | (Level 1) | rhbtyzfcza(alluhzqudt) = jqfhgwtcgw zpxggoeuyg (iynxmcuwqf, fnjrfegsof - bfxkzxsvkp) View more | - | 13 May 2025 | ||
(Level 2) | curwgeapyb = mojgrlqrtg heirykfjnb (jwcixmbrut, dzoauwghpi - qyacpsqvyq) View more |





